Rilonacept: all 25 studies that test it
Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.
- Rilonacept in Subjects With Cardiac SarcoidosisRecruitingNCT06660732Phase 2
- A Pilot Study of KPL-914 in Recurrent PericarditisCompletedNCT03980522Phase 2Results posted
- Study to Assess the Efficacy and Safety of Rilonacept Treatment in Participants With Recurrent PericarditisCompletedNCT03737110Phase 3Results posted
- A Safety and Efficacy Study of Mycophenolate Mofetil and Rilonacept in Patients With Alcoholic HepatitisCompletedNCT01903798Phase 2Results posted
- Rilonacept (Arcalyst ®) in the Treatment of Subacromial BursitisCompletedNCT01830699Not applicableResults posted
- Rilonacept for Deficiency of the Interleukin-1 Receptor Antagonist (DIRA)CompletedNCT01801449Phase 2Results posted
- Interleukin-1 Trap to Treat Vascular Dysfunction in Chronic Kidney Disease (CKD)CompletedNCT01663103Phase 4Results posted
- IL1-TRAP, Rilonacept, in Systemic SclerosisCompletedNCT01538719Phase 1/2Results posted
- Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout FlaresTerminatedNCT01459796Phase 3Results posted
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations (PRE-SURGE 2)CompletedNCT00958438Phase 3Results posted
- Inflammation in Chronic Kidney Disease and Cardiovascular Disease - The Role of Genetics and Interleukin-1 Receptor Antagonist (IL-1ra)CompletedNCT00897715Phase 2Results posted
- Review of Safety Using Rilonacept in Preventing Gout Exacerbations (RE-SURGE)CompletedNCT00856206Phase 3Results posted
- Study Utilizing Rilonacept in Gout ExacerbationsCompletedNCT00855920Phase 3Results posted
- PREventative Study Against URate-lowering Drug-induced Gout Exacerbations 1CompletedNCT00829829Phase 3Results posted
- Study of the Safety and Effectiveness of Rilonacept for the Prevention of Gout FlaresCompletedNCT00610363Phase 2Results posted
- Rilonacept for Treatment of Familial Mediterranean Fever (FMF)CompletedNCT00582907Phase 2Results posted
- Safety and Effectiveness of Rilonacept for Treating Systemic Juvenile Idiopathic Arthritis in Children and Young AdultsCompletedNCT00534495Phase 2Results posted
- Rilonacept to Improve Artery Function in Patients With AtherosclerosisCompletedNCT00417417Phase 2Results posted
- Rilonacept for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)CompletedNCT00288704Phase 3Results posted
- Interleukin-1 Trap to Treat Autoinflammatory DiseasesCompletedNCT00094900Phase 2Results posted
- Rilonacept for Treatment of Autoimmune Neurosensory Hearing LossStatus unknownNCT02828033Early Phase 1
- Study to Evaluate the Safety and Tolerability of Two Doses of Rilonacept in Pediatric Subjects With Active Systemic Juvenile Idiopathic Arthritis (SJIA)CompletedNCT01803321Phase 1
- Safety and Tolerability of Rilonacept in Muckle-Wells Syndrome (MWS) or Schnitzler Syndrome (SchS)CompletedNCT01045772Phase 2
- Rilonacept in Diabetes Mellitus Type 1: Safety StudyCompletedNCT00962026Phase 1
- Study of the Safety and Effectiveness of Rilonacept (IL-1 Trap) Administered Subcutaneously in Subjects With Non Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) and AnemiaWithdrawnNCT00609544Phase 2